a worldwide phase iii trial treating aml with pracinostat
Published 6 years ago • 275 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:46
pracinostat for aml update: follow-up analysis and phase iii trial
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:01
novel treatment paradigms for aml at ash 2021
-
2:44
the global expansion of modern aml therapy through the international consortium on acute leukemia
-
1:39
phase i/ii trial of adct-602 in b-all
-
3:37
the future of aml treatment
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
47:33
chapter 46 alteration in cellular regulation hematological or neoplastic disorders
-
16:04
acute lymphoblastic leukemia (all) - symptoms, pathogenesis, diagnosis - down syndrome - hematology
-
5:25
factors that influence prognosis in sm-ahn
-
2:34
the evolution of the aml treatment paradigm
-
2:19
phase i trial of ca-4948 in aml or mds
-
5:01
treatment options for high-risk aml
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:13
haploidentical sct for the treatment of secondary aml
-
3:26
developments in the treatment of patients with flt3-mutated aml
-
0:53
an overview of optimal sequencing therapy in aml
-
3:24
molecular profiling to determine treatment for all and aml
-
2:18
multi-dimensional analysis of the mutational landscape of aml
-
5:14
phase ii trial: atir for all following haploidentical hematopoietic cell transplant